Evaluation of cannabidiol-based products in Brazil: how can current regulations influence their labeling quality?

Journal of Cannabis Research, Journal Year: 2025, Volume and Issue: 7(1)

Published: Feb. 22, 2025

Abstract There is concern about the quality of cannabis-based products used in Brazil, mainly cannabidiol (CBD). This study aimed to evaluate labeling on CBD marketed Brazil authorized by two regulations – N660/2022 imported and N327/2019 with temporary trade permits whether there were differences between them concerning four domains: prescription, good manufacturing practices (GMP), laboratory tests, safety use. Determined was based a score 45 criteria divided per domain weights from 1 3 (according relevance for users' prescribers' safety) built public information provided product manufacturers/representatives websites e-mail consultations. The classified as very satisfactory, or not represented median interquartile range. Between N327 N660 products, scores compared using Mann–Whitney U-test. All tests considered two-tailed hypotheses significance level 5%. After applying inclusion criteria, 148 selected, 105 evaluated. Most evaluated satisfactory (47), followed (39) (19). presented that more accessible than products. Similarly, significant difference groups domains prescription use; showed better results those N660. contributes urgent debate risks widely Brazil.

Language: Английский

Cannabis Comes Into the Light at the End of a Long Tunnel

Clinical Therapeutics, Journal Year: 2023, Volume and Issue: 45(6), P. 483 - 485

Published: June 1, 2023

Language: Английский